NCT04981639View on ClinicalTrials.gov

TAP and IMS for HIPEC

PHASE3CompletedINTERVENTIONAL
Enrollment

81

Participants

Timeline

Start Date

August 21, 2021

Primary Completion Date

June 14, 2022

Study Completion Date

June 14, 2022

Conditions
Cytoreductive Surgery
Interventions
PROCEDURE

IVPCA

Intravenous patient controlled analgesia will be performed.

PROCEDURE

TAP

Transversus abdominis plane block will be performed.

PROCEDURE

IMS

Intramuscular electrical stimulation will be performed.

Trial Locations (1)

Unknown

GangnamSeveranceHospital, Seoul

All Listed Sponsors
lead

Gangnam Severance Hospital

OTHER

NCT04981639 - TAP and IMS for HIPEC | Biotech Hunter | Biotech Hunter